Polyethylene Glycol 3350
Medically reviewed by Drugs.com. Last updated on Apr 16, 2024.
Excipient (pharmacologically inactive substance)
What is it?
Polyethylene glycol, referred to as PEG, is used as an inactive ingredient in the pharmaceutical industry as a solvent, plasticizer, surfactant, ointments, and suppository base, and tablet and capsule lubricant. PEG has low toxicity with systemic absorption less than 0.5%.
PEGylation occurs when PEGs are attached to various protein medications, allowing for greater solubility for certain drugs. Examples of PEGylated medications include PEG-interferon alpha (Pegintron) and PEG-filgrastim (Neulasta). PEG is also available as a bowel prep for colonoscopy procedures and as a laxative.[1]
PEG 400 indicates the average molecular weight of the specific PEG at 400.[2] PEG 3350 is a laxative available over-the-counter by the name of Miralax. In this case, PEG is considered an "active" ingredient, even though systemic absorption is less than 0.5%.
Some examples of medications containing Polyethylene Glycol 3350
- Amoxicillin Trihydrate 500 mg
- Amoxicillin Trihydrate 875 mg
- Cetirizine Hydrochloride 10 mg
- Descovy 200 mg / 25 mg
- Famotidine 40 mg
- Famotidine 20 mg
- Gabapentin 600 mg
- Glipizide Extended-Release 10 mg
- Levetiracetam 500 mg
- Metformin Hydrochloride 500 mg
- Metoprolol Tartrate 25 mg
- Metronidazole 500 mg
- Metronidazole 250 mg
- Nifedipine Extended-Release 30 mg
- Risperidone 1 mg
- Sildenafil Citrate 100 mg
- Sildenafil Citrate 50 mg
- Sildenafil Citrate 20 mg (base)
- Venlafaxine Hydrochloride Extended Release 37.5 mg
- Xarelto 20 mg
References
- Dave RH. Overview of pharmaceutical excipients used in tablets and capsules. Drug Topics (online). Advanstar. 10/24/2008 http://drugtopics.modernmedicine.com/drugtopics/Top+News/Overview-of-pharmaceutical-excipients-used-in-tabl/ArticleStandard/Article/detail/561047. Accessed 08/19/2011
- ThermoScientific. PEG (Polyethylene Glycol) Reagents http://www.piercenet.com/products/browse.cfm?fldID=12D97D8D-5056-8A76-4E95-9EA0D0B54BDB Accessed 08/19/2011
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.